SOCS3 and type 2 diabetes mellitus: Altered expression of miRNAs was observed in both T1DM[28] and T2DM[29] including miR-185, which was shown to influence β-cell activity by targeting the mRNA of suppressor of cytokine signaling 3 (SOCS3)[30].